ANXA1 and diabetes mellitus: As endogenous ANXA1 protected against the development experimental diabetes and treatment with hrAXNXA1 improved the diabetic phenotype of HFD-fed mice, we next investigated the potential mechanisms underlying the observed beneficial effects of both hrANXA1 and endogenous ANXA1.